CAMBRIDGE, Mass. & COLUMBUS, Ohio--(BUSINESS WIRE)--Solid Biosciences Inc. (Solid, Nasdaq: SLDB), a life sciences company focused on advancing meaningful therapies for Duchenne muscular dystrophy ...
Partnership to Bolster Solid Biosciences’ Gene Therapy Pipeline, Including AAV Process Development, Scale Up and cGMP Manufacturing Services Forge will provide an adeno-associated viral (AAV) vector ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results